Cyclacel Pharma (CYCC) Reports Q3 Loss of $0.86
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Total other income (expense): 77K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Financial Fact:
Total other income (expense): 77K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.86), versus ($0.91) reported last year. Revenue for the quarter came in at $0 , versus $0 reported last year.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Goldman Sachs Starts Infratil New Zealand (IFT:NZ) at Buy
- Pfizer reaffirms 2026 guidance after CFO transition news
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
